StonvexLoading…
StonvexStonvexStonvexCore line items from EIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $19.32B | $17.60B | $16.34B | $17.22B |
Operating Income | $7.09B | $2.93B | $2.63B | $1.48B |
Net Income | $4.46B | $1.28B | $1.20B | $824.00M |
EPS (Diluted) | $11.55 | $3.31 | $3.11 | $1.60 |
Total Assets | $94.03B | $85.58B | $81.76B | $78.04B |
Total Liabilities | $74.77B | $67.84B | $63.81B | $60.52B |
Cash & Equivalents | $158.00M | $193.00M | $345.00M | $914.00M |
Free Cash Flow OCF − CapEx | $-715.00M | $-693.00M | $-2.05B | $-2.56B |
Shares Outstanding | 384.79M | 384.78M | 383.92M | 382.21M |